Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Remifentanil for Postoperative Sore Throat in Spine Surgery
NCT05345574Unknown
- Sponsor
- Yeungnam University College of Medicine
- Start
- Dec 2018
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in postoperative sore throat (POST) (2 arms), sponsored by Yeungnam University College of Medicine. Primary endpoints: incidence of postoperative sore throat at rest, incidence of postoperative sore throat at swallowing and 2 more. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
postoperative sore throat (POST)
Beyond the preview
Go deeper on NCT05345574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05345574.